Laboratory Corporation of America (LabCorp; Burlington, North Carolina) said it has entered into a definitive agreement to acquire Genzyme Genetics, a business unit of Genzyme (Cambridge, Massachusetts) in an all-cash deal valued at $925 million, and increasing the odds that Sanofi-Aventis (Paris) could raise its acquisition bid. (Medical Device Daily) Read More
